On Feb. 3, the U.S. Food and Drug Administration (FDA) permitted marketing of the Seeker System for the screening of four, rare Lysosomal Storage Disorders in newborns. Read more

New newborn screening for metabolic disorders

Urinary incontinence in nursing-home residents associated with increased mortality risk

Robotic nurses: No substitute for real RNs

In Brief

Electronic cigarettes are not harmless

FDA teething tablet warning

Healthcare workforce needs

ANA News

Headlines from the Hill

Welcome to ANA on the Frontline

Kicking off the “Year of the Healthy Nurse” Worksite wellness

A nurse-driven community education program for older adults

National Magnet Nurse of the Year® 2016 award winners

FDA approves new drug for CIC

MRI may help predict response to antidepressants

Exercise guidelines for patients with type 1 diabetes

New guideline for treating hypertension

FDA, EPA releases fish consumption advice for specific groups

Subduing stress: A physiology-based approach

Hook-and-loop alarm belt: A vital component in a fall-prevention toolkit

Give yourself the gift of self-affirmation

A conversation with Patricia Flatley Brennan

“My research article was accepted for publication!”

Cannabis use in older adults

ADA releases position statement on diabetic neuropathy

January 2017 Vol. 1 No. 1

Patient on the precipice

Enteral feeding: Indications, complications, and nursing care

FDA approves first drug for treating spinal muscular dystrophy

Indoor smoking bans reduce children’s asthma ED visits

Continuous-waveform capnography: A crucial tool for ED clinicians

Managing medications for hospital patients with Parkinson disease

ANA’s Health Risk Appraisal: Three years later

No time like the present to get healthy

Breaking down diversability barriers to improve patient well-being

Guns and nurses